Roivant May Take On AbbVie In Uveitis With Strong Phase II Efficacy

 
• By Joseph Haas
Uveitis
Roivant plans to move into Phase III with its non-infectious uveitis drug • Source: Shutterstock

More from Strategy

More from Business